Louvain-la-Neuve, Belgium
Louvain-la-Neuve, Belgium

The Catholic University of Leuven, , was the largest, oldest and most prominent university in Belgium. The university was founded in 1425 as the University of Leuven by John IV, Duke of Brabant and approved by a Papal bull by Pope Martin V.During France's occupation of Belgium in the French Revolutionary Wars, the French Republic closed the university. After Belgium was annexed by the United Kingdom of the Netherlands, the State University of Louvain was founded in 1816, lasting until 1835. In 1834, a few years after Belgium gained its independence, the university was "re-founded", and would become known as the Catholic University of Leuven, and it is usually identified with the Old University.In 1968, the university split to form two institutions: Katholieke Universiteit Leuven, Dutch-speaking, situated primarily in Leuven; and Université catholique de Louvain, French-speaking, situated primarily in nearby Louvain-la-Neuve.This entry deals with the historic university, 1425–1797 and 1834–1968. For the current successor institutions and their separate development since 1968, see the individual articles linked above. Wikipedia.


Time filter

Source Type

Patent
Catholic University of Louvain | Date: 2015-04-30

Transmission (10) comprising a sun (1), a planet carrier (4), a first planet (21) having a first axis of revolution (41) and a first lateral surface (31) that is nonparallel to it, and a ring (3). When there is a relative movement between said first planet (21) and said ring (3) for a constant transmission ratio, a force of power transmission, Formula (I), between said first planet (21) and said ring (3) defines a plane (55). The transmission (10) comprises rolling means (15) for allowing a movement of translation between said ring (3) and said first planet (21) along a direction of translation (65) that is perpendicular to said plane (55) such that different transmission ratios can be obtained, corresponding to different coupling points (8) between said first lateral surface (31) and said ring (3) along said direction of translation (65).


Patent
Catholic University of Louvain | Date: 2017-01-18

The invention provides an electric machine comprising a radial bearing (10,11) for supporting a shaft of said electric machine, comprising an inductor (40) having an inductor axle (30), generating a magnetic field having p pole pairs, p being equal to or larger than 1; a motor/generator armature winding (170) having turns (100) arranged around an armature axis (35), magnetically coupled to said magnetic field, and connected to a source in such a manner that a torque is produced when a current is fed into said motor/generator armature winding (170) when said electric machine is a motor or connected to a load in such a manner that a current is produced in said load when said inductor is rotated, when said electric machine is a generator; a bearing armature winding (70) having turns (100) disposed around said armature axis (35), magnetically coupled to said magnetic field, and connected in a closed circuit in such a manner that the net flux variation intercepted by said armature winding (70) when said inductor (40) and said armature winding (70) are in rotation with respect to each other is zero when said inductor axle (30) and said armature axis (35) coincide and is different from zero when said inductor axle (30) and axis (35) do not coincide; a gap (50) between said inductor (40) and said winding (70). Said bearing armature winding (70) comprises p-1 or p+1 pole pairs. In a preferred embodiment, the two windings are combined in one multifunction winding.


Grant
Agency: European Commission | Branch: H2020 | Program: MSCA-ITN-ETN | Phase: MSCA-ITN-2016 | Award Amount: 3.93M | Year: 2017

We propose a European Training Network that will provide a total of 540 ESR-months of training in Monte Carlo event generator physics and techniques, and related applications in experimental particle physics. Monte Carlo event generators are central to high energy particle physics. They are used by almost all experimental collaborations to plan their experiments and analyze their data, and by theorists to simulate the complex final states of the fundamental interactions that may signal new physics. We will build on the success of our current MCnetITN, by creating a European Training Network incorporating all the authors of current general purpose event generators, with the main purposes of: (a) training a large section of our user base, using annual schools on the physics and techniques of event generators and short-term studentships of Early Stage Researchers as a conduit for transfer of knowledge to the wider community; (b) training the next generation of event generator authors through dedicated PhD studentships; (c) providing broader training in transferable skills through our research, through dedicated training in entrepreneurship and employability and through secondments to non-academic partners. We will achieve these training objectives both through dedicated activities and through our research activities: (d) developing the next generation of higher precision event generators and supporting them for use throughout the LHC era and beyond; (e) playing a central role in the analysis of LHC data and the discovery of new physics there; and (f) extracting the maximum potential from existing data to constrain the modeling of the higher-energy data from the LHC and future experiments.


Grant
Agency: European Commission | Branch: H2020 | Program: CSA | Phase: INFRADEV-02-2016 | Award Amount: 4.00M | Year: 2017

Sustainable food security and increasing availability of plant biomass for human nutrition and bioindustries is the key challenge for the coming decades. The analysis of crop performance with respect to structure, function, quality and interaction with the environment (phenotyping) remains the bottleneck for the exploitation of crop genetic diversity required for the enhancement of plant productivity and progress in plant breeding. This requires substantial and concerted action to develop and to increase the availability of phenotyping infrastructures. The European Strategic Forum for Research Infrastructure (ESFRI) has identified Plant Phenotyping as a priority for the European research area and EMPHASIS has been listed on the ESFRI ROADMAP as an infrastructure project to develop and implement a pan-European plant phenotyping infrastructure. The project EMPHASIS-PREP will provide the basis for the establishment the legal framework, the business plan and preparation of an information system for a sustainable and innovative pan-European infrastructure for plant phenotyping within the framework of EMPHASIS. EMPHASIS-PREP will establish a transparent, open and inclusive process, the project partners will foster efficient work in the project in close cooperation with the European plant phenotyping community and all stakeholders. EMPHASIS-PREP includes four major steps: i) mapping (infrastructure, funders, access procedure and models, stakeholder community, e-infrastructure, imaging approaches, legal and governance scenarios); ii) gapping - analysing the gaps and limitations based on the mapping activities; iii) developing strategies to address the gaps; iv) combining the strategies in a business plan for future operation of EPMPHASIS within a corresponding legal framework.


Grant
Agency: European Commission | Branch: H2020 | Program: IA | Phase: ICT-25-2016-2017 | Award Amount: 4.62M | Year: 2017

The global goal of the CYBERLEGs Plus Plus project is to validate the technical and economic viability of the powered robotic ortho-prosthesis developed within the framework of the FP7-ICT-CYBERLEGs project as a means to enhance/restore the mobility of transfemoral amputees and to enable them to perform locomotion tasks such as ground-level walking, walking up and down slopes, climbing/descending stairs, standing up, sitting down and turning in scenarios of real life. Restored mobility will allow amputees to perform physical activity thus counteracting physical decline and improving the overall health status and quality of life. This consortium will pursue the achievement of the global goal by addressing four specific innovation objectives. 1) Further developments of the existing CYBERLEGs hardware modules, namely the 2-degree-of-freedom active transfemoral prosthesis, the active wearable orthotic device, and the wearable sensory apparatus. 2) Further developments of the existing multi-layered CYBERLEGs control system, to enhance its reliable use in real-life scenarios. 3) Carrying out two multi-centre clinical studies, that validate the therapeutic potentialities and the economic viability of a robotic ortho-prosthesis which restores the amputees locomotion abilities in scenarios of activities of daily living. 4) Implementation of a 3-phase strategy to foster the start of the market exploitation within the time frame of the CLs\\ project. This proposal focuses on the demonstration in an operational environment (TRL=7) from both the technical and economic viability view point of a modular robotics technology for healthcare, with the ultimate goal of fostering its market exploitation. The proposals involve players from academia, end users, as well as robotics and healthcare industry. Therefore this proposal fits the specific challenge of the scope c of the call H2020-ICT-25-2016-2017.


Grant
Agency: European Commission | Branch: H2020 | Program: SGA-RIA | Phase: FETFLAGSHIP | Award Amount: 89.00M | Year: 2016

This project is the second in the series of EC-financed parts of the Graphene Flagship. The Graphene Flagship is a 10 year research and innovation endeavour with a total project cost of 1,000,000,000 euros, funded jointly by the European Commission and member states and associated countries. The first part of the Flagship was a 30-month Collaborative Project, Coordination and Support Action (CP-CSA) under the 7th framework program (2013-2016), while this and the following parts are implemented as Core Projects under the Horizon 2020 framework. The mission of the Graphene Flagship is to take graphene and related layered materials from a state of raw potential to a point where they can revolutionise multiple industries. This will bring a new dimension to future technology a faster, thinner, stronger, flexible, and broadband revolution. Our program will put Europe firmly at the heart of the process, with a manifold return on the EU investment, both in terms of technological innovation and economic growth. To realise this vision, we have brought together a larger European consortium with about 150 partners in 23 countries. The partners represent academia, research institutes and industries, which work closely together in 15 technical work packages and five supporting work packages covering the entire value chain from materials to components and systems. As time progresses, the centre of gravity of the Flagship moves towards applications, which is reflected in the increasing importance of the higher - system - levels of the value chain. In this first core project the main focus is on components and initial system level tasks. The first core project is divided into 4 divisions, which in turn comprise 3 to 5 work packages on related topics. A fifth, external division acts as a link to the parts of the Flagship that are funded by the member states and associated countries, or by other funding sources. This creates a collaborative framework for the entire Flagship.


Grant
Agency: European Commission | Branch: H2020 | Program: RIA | Phase: FETOPEN-01-2016-2017 | Award Amount: 4.58M | Year: 2017

M-Cube aims at changing the paradigm of High-Field MRI and Ultra High-Field antennas to offer a much better insight on the human body and enable earlier detection of diseases. Our main objective is to go beyond the limits of MRI clinical imaging and radically improve spatial and temporal resolutions. The clinical use of High-field MRI scanners is drastically limited due to the lack of homogeneity and to the Specific Absorption Rate (SAR) of the Radio Frequency (RF) fields associated with the magnetic resonance. The major way to tackle and solve these problems consists in increasing the number of active RF antennas, leading to complex and expensive solutions. M-Cube solution relies on innovative systems based upon passive metamaterial structures to avoid multiple active elements. These systems are expected to make High-Field MRI fully diagnostically relevant for physicians. To achieve these expectations, M-Cube consortium will develop a disruptive metamaterial antenna technology. This we will able us to tackle both the lack of homogeneity and SAR barriers. Metamaterials are composite structured manmade materials designed to produce effective properties unavailable in nature (e.g. negative optical index). They allow us to tailor electromagnetic waves at will. Thus, the scientifically ambitious idea is to develop antennas based on this unique ability for whole body coil. This technological breakthrough will be validated by preclinical and clinical tests with healthy volunteers. M-Cube gathers an interdisciplinary consortium composed of academic leaders in the field, eight universities, and two promising SMEs. Physicists, medical doctors and industrial actors will work closely all along the implementation of the project to guarantee the success this novel approach, a patient-centered solution which will pave the way for a more accurate diagnosis in the context of personalized medicine and will enable to detect a disease much earlier that is currently possible.


Grant
Agency: European Commission | Branch: H2020 | Program: MSCA-ITN-ETN | Phase: MSCA-ITN-2016 | Award Amount: 3.93M | Year: 2017

Train2Target is a multidisciplinary European Training Network built to address the challenge of the discovery of alternative antimicrobials. Innovative strategies to deliver a next generation of drugs are urgently needed. The alarming threats and spread of multi-drug resistant bacteria is currently leaving clinicians with very limited options to combat infections especially those from Gram-negative pathogens. The Train 2Target research programme focuses on the assembly of the well-known bacterial cell envelope from a new perspective. Indeed it aims to inhibit novel targets in envelope biogenesis by altering the function and misbalancing the coordination of envelope assembly machines, which build and assemble the Gram-negative bacterial envelope. A wide variety of chemical classes and compounds sources will be screened using innovative biochemical, biophysical and genetic assays to identify valuable hit scaffolds to be optimized into druggable leads. The high quality and credibility of our consortium is ensured by a strong interdisciplinary academia-industry partnership to encompass different complementary expertise ranging from microbiology, bacterial genetics, biochemistry, cell imaging, structural biology, biophysics and chemical synthesis. Our 9 academic groups are all renowned leaders in the cell envelope biogenesis field, whereas the complementary 5 SMEs and 3 Industry partners are specialised in drug discovery and development of novel anti-infective drugs. This unique combination of scientific excellence and industrial know-how in drug discovery covers the entire process from the design to the implementation of innovative antibacterial strategies and lead identification. Train2Target also represents a unique research platform to train 15 Early Stage Researchers and equip them with the necessary scientific and transferable skills that will make them highly competitive for both top European research institutions and the pharma/biotech job market.

Loading Catholic University of Louvain collaborators
Loading Catholic University of Louvain collaborators